Naloxone changes self-ratings but not performance in normal subjects

Area of Science:

• Neuroscience
• Pharmacology
• Psychology

Background:

• Naloxone is a primary antagonist used to reverse opioid effects.
• Its impact on cognitive performance and mood beyond opioid reversal is not fully understood.

Purpose of the Study:

• To investigate the effects of intravenous naloxone on cognitive performance and subjective mood in healthy volunteers.
• To determine if naloxone's effects are dose-dependent and if they extend beyond opiate receptor blockade.

Main Methods:

• 12 healthy student volunteers received single intravenous doses of naloxone (0.8 mg and 1.6 mg).
• Participants completed various performance tasks and rated their mood and bodily symptoms.
• Subjective and objective measures were assessed at specific time points post-administration.

Main Results:

• Naloxone administration did not significantly alter performance on any measured tasks.
• At 5 minutes post-1.6 mg naloxone, subjects reported increased feelings of being troubled, mentally slow, incompetent, withdrawn, and physically tired, with decreased irritability.
• At 65 minutes post-1.6 mg naloxone, subjects reported feeling more muzzy and incompetent, but also more irritable compared to baseline.

Conclusions:

• Naloxone's effects on mood and cognition in healthy individuals are complex and may not be solely attributable to opiate receptor blockade.
• The observed subjective changes suggest potential interactions with other neurotransmitter systems or central nervous system pathways.
• Further research is warranted to elucidate the precise mechanisms underlying naloxone's non-opioid-related effects.